BACKGROUND: The genetic analysis of human primary immunodeficiencies has defined the contribution of specific cell populations and molecular pathways in the host defense against infection. Disseminated infection caused by bacille Calmette-Guérin (BCG) vaccines is an early manifestation of primary immunodeficiencies, such as severe combined immunodeficiency. In many affected persons, the cause of disseminated BCG disease is unexplained. METHODS: We evaluated an infant presenting with features of severe immunodeficiency, including early-onset disseminated BCG disease, who required hematopoietic stem-cell transplantation. We also studied two otherwise healthy subjects with a history of disseminated but curable BCG disease in childhood. We characterized the monocyte and dendritic-cell compartments in these three subjects and sequenced candidate genes in which mutations could plausibly confer susceptibility to BCG disease. RESULTS: We detected two distinct disease-causing mutations affecting interferon regulatory factor 8 (IRF8). Both K108E and T80A mutations impair IRF8 transcriptional activity by disrupting the interaction between IRF8 and DNA. The K108E variant was associated with an autosomal recessive severe immunodeficiency with a complete lack of circulating monocytes and dendritic cells. The T80A variant was associated with an autosomal dominant, milder immunodeficiency and a selective depletion of CD11c+CD1c+ circulating dendritic cells. CONCLUSIONS: These findings define a class of human primary immunodeficiencies that affect the differentiation of mononuclear phagocytes. They also show that human IRF8 is critical for the development of monocytes and dendritic cells and for antimycobacterial immunity. (Funded by the Medical Research Council and others.).
BACKGROUND: The genetic analysis of human primary immunodeficiencies has defined the contribution of specific cell populations and molecular pathways in the host defense against infection. Disseminated infection caused by bacille Calmette-Guérin (BCG) vaccines is an early manifestation of primary immunodeficiencies, such as severe combined immunodeficiency. In many affected persons, the cause of disseminated BCG disease is unexplained. METHODS: We evaluated an infant presenting with features of severe immunodeficiency, including early-onset disseminated BCG disease, who required hematopoietic stem-cell transplantation. We also studied two otherwise healthy subjects with a history of disseminated but curable BCG disease in childhood. We characterized the monocyte and dendritic-cell compartments in these three subjects and sequenced candidate genes in which mutations could plausibly confer susceptibility to BCG disease. RESULTS: We detected two distinct disease-causing mutations affecting interferon regulatory factor 8 (IRF8). Both K108E and T80A mutations impair IRF8 transcriptional activity by disrupting the interaction between IRF8 and DNA. The K108E variant was associated with an autosomal recessive severe immunodeficiency with a complete lack of circulating monocytes and dendritic cells. The T80A variant was associated with an autosomal dominant, milder immunodeficiency and a selective depletion of CD11c+CD1c+ circulating dendritic cells. CONCLUSIONS: These findings define a class of human primary immunodeficiencies that affect the differentiation of mononuclear phagocytes. They also show that human IRF8 is critical for the development of monocytes and dendritic cells and for antimycobacterial immunity. (Funded by the Medical Research Council and others.).
Authors: David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen Journal: J Comput Chem Date: 2005-12 Impact factor: 3.376
Authors: Ben Webb; Andrej Sali; Narayanan Eswar; Marc A Marti-Renom; M S Madhusudhan; David Eramian; Min-Yi Shen; Ursula Pieper Journal: Curr Protoc Bioinformatics Date: 2006-10
Authors: Karine Crozat; Rachel Guiton; Vanessa Contreras; Vincent Feuillet; Charles-Antoine Dutertre; Erwan Ventre; Thien-Phong Vu Manh; Thomas Baranek; Anne K Storset; Jacqueline Marvel; Pierre Boudinot; Anne Hosmalin; Isabelle Schwartz-Cornil; Marc Dalod Journal: J Exp Med Date: 2010-05-17 Impact factor: 14.307
Authors: Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa Journal: J Exp Med Date: 2010-05-17 Impact factor: 14.307
Authors: Alyssa D Smith; Chunwan Lu; Daniela Payne; Amy V Paschall; John D Klement; Priscilla S Redd; Mohammed L Ibrahim; Dafeng Yang; Qimei Han; Zhuoqi Liu; Huidong Shi; Thomas J Hartney; Asha Nayak-Kapoor; Kebin Liu Journal: Cancer Res Date: 2020-06-17 Impact factor: 12.701
Authors: John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu Journal: J Clin Invest Date: 2018-11-05 Impact factor: 14.808
Authors: Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li Journal: Mol Immunol Date: 2018-03-15 Impact factor: 4.407
Authors: Jeremy D Waight; Colleen Netherby; Mary L Hensen; Austin Miller; Qiang Hu; Song Liu; Paul N Bogner; Matthew R Farren; Kelvin P Lee; Kebin Liu; Scott I Abrams Journal: J Clin Invest Date: 2013-09-16 Impact factor: 14.808